PD-L1 inhibition improves response of pancreatic cancer to radiotherapy

A. Azad; Z. D'Costa; S. Y. Lim; O. Sansom; W. G. McKenna; R. Muschel; E. Fokas

doi:10.1016/S0167-8140(16)31533-X

PD-L1 inhibition improves response of pancreatic cancer to radiotherapy

A. Azad, Z. D'Costa, S. Y. Lim, O. Sansom, W. G. McKenna, R. Muschel, E. Fokas

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	OC-0284
Pages (from-to)	S133
Number of pages	1
Journal	Radiotherapy and Oncology
Volume	119
Issue number	Supplement 1
DOIs	https://doi.org/10.1016/S0167-8140(16)31533-X
Publication status	Published - 2 Apr 2016
Externally published	Yes
Event	European Society for Radiotherapy and Oncology - Turin, Italy Duration: 29 Apr 2016 → 3 May 2016

Keywords

Programmed cell death 1 receptors
Pancreatic cancer treatment
Cancer patients
Pancreatic cancer
Cancer radiotherapy
Treatment effectiveness

Access to Document

10.1016/S0167-8140(16)31533-X

Cite this

@article{19887e4dcf7a400c808d5ea5debf9d1b,

title = "PD-L1 inhibition improves response of pancreatic cancer to radiotherapy",

keywords = "Programmed cell death 1 receptors, Pancreatic cancer treatment, Cancer patients, Pancreatic cancer, Cancer radiotherapy, Treatment effectiveness",

author = "A. Azad and Z. D'Costa and Lim, {S. Y.} and O. Sansom and McKenna, {W. G.} and R. Muschel and E. Fokas",

year = "2016",

month = apr,

day = "2",

doi = "10.1016/S0167-8140(16)31533-X",

language = "English",

volume = "119",

pages = "S133",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier",

number = "Supplement 1",

note = "European Society for Radiotherapy and Oncology, ESTRO 35 ; Conference date: 29-04-2016 Through 03-05-2016",

}

TY - JOUR

T1 - PD-L1 inhibition improves response of pancreatic cancer to radiotherapy

AU - Azad, A.

AU - D'Costa, Z.

AU - Lim, S. Y.

AU - Sansom, O.

AU - McKenna, W. G.

AU - Muschel, R.

AU - Fokas, E.

PY - 2016/4/2

Y1 - 2016/4/2

KW - Programmed cell death 1 receptors

KW - Pancreatic cancer treatment

KW - Cancer patients

KW - Pancreatic cancer

KW - Cancer radiotherapy

KW - Treatment effectiveness

U2 - 10.1016/S0167-8140(16)31533-X

DO - 10.1016/S0167-8140(16)31533-X

M3 - Meeting abstract

SN - 0167-8140

VL - 119

SP - S133

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

IS - Supplement 1

M1 - OC-0284

T2 - European Society for Radiotherapy and Oncology

Y2 - 29 April 2016 through 3 May 2016

ER -